Executive order announced to accelerate psychedelic research and prompt rescheduling reviews
April 19, 2026 | Department of State, Executive, Federal
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
A presenter announced an executive order that aims to accelerate access to medical research and treatments based on psychedelic drugs.
The order "will remove legal impediments that block American researchers, scientists, physicians, and clinicians from properly spreading these medicines," an agency official said, and officials are coordinating with the DEA (the Drug Enforcement Administration) and the Department of Justice to "begin rescheduling reviews after successful phase 3 trials." The announcement did not specify timelines, implementation steps, or an effective date.
Why it matters: supporters said the change could open avenues for clinical trials and therapeutic use for veterans and civilians with treatment-resistant conditions. A separate speaker linked the policy shift to the 1970 Controlled Substances Act, saying that the law — passed during the Nixon administration — had kept the drugs illegal for decades and that the order marks a change from that status.
What speakers said: the presenter opened the event by saying, "Today, I'm pleased to announce historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs." The agency official added, "This executive order will remove legal impediments that block American researchers, scientists, physicians, and clinicians from properly spreading these medicines." That official also said, "We're also coordinating with the DEA and the Department of Justice to begin rescheduling reviews after successful phase 3 trials." Another presenter argued, "These drugs are illegal not because they're harmful. They're illegal because of the 1970 Controlled Substances Act that was passed by the Richard Nixon administration," and said, "For 56 years, we've lived under those terrible conditions. We're free of that now."
No formal vote or regulatory rescheduling decision was recorded during the event, and the announcement gave no operational detail about how or when the Drug Enforcement Administration or Department of Justice will carry out any rescheduling reviews. The presenters concluded the event with expressions of gratitude; one speaker thanked "all these people that we see next to me and thanks to president Trump," calling the policy change "an epic epic victory for all humanity."
The order "will remove legal impediments that block American researchers, scientists, physicians, and clinicians from properly spreading these medicines," an agency official said, and officials are coordinating with the DEA (the Drug Enforcement Administration) and the Department of Justice to "begin rescheduling reviews after successful phase 3 trials." The announcement did not specify timelines, implementation steps, or an effective date.
Why it matters: supporters said the change could open avenues for clinical trials and therapeutic use for veterans and civilians with treatment-resistant conditions. A separate speaker linked the policy shift to the 1970 Controlled Substances Act, saying that the law — passed during the Nixon administration — had kept the drugs illegal for decades and that the order marks a change from that status.
What speakers said: the presenter opened the event by saying, "Today, I'm pleased to announce historic reforms to dramatically accelerate access to new medical research and treatments based on psychedelic drugs." The agency official added, "This executive order will remove legal impediments that block American researchers, scientists, physicians, and clinicians from properly spreading these medicines." That official also said, "We're also coordinating with the DEA and the Department of Justice to begin rescheduling reviews after successful phase 3 trials." Another presenter argued, "These drugs are illegal not because they're harmful. They're illegal because of the 1970 Controlled Substances Act that was passed by the Richard Nixon administration," and said, "For 56 years, we've lived under those terrible conditions. We're free of that now."
No formal vote or regulatory rescheduling decision was recorded during the event, and the announcement gave no operational detail about how or when the Drug Enforcement Administration or Department of Justice will carry out any rescheduling reviews. The presenters concluded the event with expressions of gratitude; one speaker thanked "all these people that we see next to me and thanks to president Trump," calling the policy change "an epic epic victory for all humanity."
View the Full Meeting & All Its Details
This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.
✓
Watch full, unedited meeting videos
✓
Search every word spoken in unlimited transcripts
✓
AI summaries & real-time alerts (all government levels)
✓
Permanent access to expanding government content
30-day money-back guarantee
